Liver transplantation for unresectable colorectal liver metastasis: who will get the benefit?
The prognosis of patients with unresectable colorectal liver metastases (CRLM) has been dismal in the past with chemotherapy offering only rare 5-year survival in the range of about 10%. Liver transplantation is the most radical form of liver resection and initially was thought to be a promising treatment for liver cancer. The initial experience with liver transplantation for primary hepatocellular carcinoma (HCC) was disappointing. Only a better understanding of patient selection and tumor biology allowed transplantation to become a successful routine therapy for HCC.